STOCK TITAN

Royalty Pharma: former affiliate plans $11.9M sale

Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

Royalty Pharma plc (RPRX) is named as issuer in a notice of a proposed sale of 206,352 Class A ordinary shares for the account of Errol B. De Souza, identified as a former affiliate. Errol Bento De Souza Revocable Trust will sell the shares, which have an aggregate market value of $11,925,082. The notice lists 445,277,344 Class A ordinary shares outstanding.

Class A ordinary shares covered by proposed sale 206,352 shares Proposed sale
Aggregate market value $11,925,082 Shares covered by the proposed sale
Class A ordinary shares outstanding 445,277,344 shares Number listed in the securities information
Shares acquired through conversion of LP Interests 125,000 shares Acquisition table lists August 7, 2026
LP Interests financial
"Conversion of LP Interests"
LP interests are ownership stakes in a limited partnership that give the holder a claim on the partnership’s profits and losses but typically little or no role in managing day-to-day operations. Think of owning a seat at a table where you share the dessert but don’t run the kitchen; for investors this matters because LP interests determine how income is distributed, how much influence you have, and how easy it is to sell your stake, all of which affect return and risk.
Aggregate Market Value financial
"Aggregate Market Value"
Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.
Revocable Trust regulatory
"Errol Bento De Souza Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
attorney-in-fact regulatory
"as agent and attorney-in-fact for Errol B. De Souza"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many RPRX shares are covered by the proposed sale?

The notice covers 206,352 Class A ordinary shares, with an aggregate market value of $11,925,082.

Who will sell the RPRX shares?

The shares will be sold by Errol Bento De Souza Revocable Trust for the account of Errol B. De Souza, identified as a former affiliate.

When is the RPRX sale expected, and which broker is named?

The approximate sale date is August 12, 2026, and J.P. Morgan Securities LLC is named as the broker.

How were some of the shares in the RPRX notice acquired?

The notice says 125,000 shares were acquired from Errol Bento De Souza after he transferred LP Interests originally received from Royalty Pharma on June 16, 2020, to the Revocable Trust on January 12, 2022. The acquisition table identifies a conversion date of August 7, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading